We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Implementation of the new EUR IVD regulation and relation with ISO15189 accreditation: Guidance is urgently required for haemostasis testing.
- Authors
Testa, Sophie; Meijer, Piet; Lasne, Dominique; Mullier, François
- Abstract
On May 26th 2017 the European Parliament and the Council of The European Union adopted the new regulation on in vitro diagnostic medical devices (IVDR)‐Regulation EU 2017/746‐planned to be applied from May 26th 2022 in substitution to the previous IVD directives (IVDD 98/79 EC). After several health and legal causes due to medical device malfunctions, the European Union (EU) extensively reviewed the previous regulatory, which had remained unchanged since 1998. Aim of the work is to analyse the effects of the new IVDR on the field of haemostasis and thrombosis testing with particular attention to specific clinical conditions. Clinical laboratories will mainly deal with three different situations: (1) Diagnostic test performed with IVDR products used according with clinical indication certified by manufacturers. (2) Diagnostic test performed with certified IVDR products without clinical validation. (3) Diagnostic test performed with reagents classified as Research Use Only (RUO). At present, only few clinical laboratories through different European countries have been prepared to the new IVDR, while many laboratories are not yet aware about crucial aspects of the new process that deeply involves laboratory medicine. In conclusion, each laboratory should be aware of the IVDR certification of the reagents/instruments used in its laboratory. There are several urgent needs regarding IVDR certification: studies about the clinical performance of haemostasis tests, guidelines for LDTs (definition and documentation), internal and external quality controls for the tests recommended/suggested in the guidance/guidelines and finally implementation and/or update of clinical and laboratory guidelines.
- Subjects
CLINICAL pathology equipment; THROMBOSIS; ACCREDITATION; GOVERNMENT regulation; HEMOSTASIS; MEDICAL equipment laws; MEDICAL protocols; EUROPEAN Union
- Publication
International Journal of Laboratory Hematology, 2022, Vol 44, p71
- ISSN
1751-5521
- Publication type
Article
- DOI
10.1111/ijlh.13936